The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of ctDNA and radiographic imaging features derived from 18F-FDG PET/CT for patients with metastatic melanoma treated with immunotherapy.
 
Mikaela R. Dell'Oro
Research Funding - AIQ Solutions
 
Ojaswita Lokre
Employment - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
 
Elin S. Gray
Research Funding - Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Patent - WO/2018/213877
Travel, Accommodations, Expenses - Thermo Fisher Scientific
 
Roslyn J. Francis
Employment - AIQ Solutions (I)
Stock and Other Ownership Interests - AIQ Solutions (I)
Consulting or Advisory Role - AIQ Solutions (Inst)
Research Funding - AIQ Solutions (Inst)
 
Timothy G. Perk
Employment - AIQ Solutions
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Patents, Royalties, Other Intellectual Property - AIQ Solutions
 
Martin A. Ebert
Honoraria - 5D Clinics
 
Michael Millward
Consulting or Advisory Role - AstraZeneca; BeiGene; IQvia; Lilly; The Limbic
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Albion Laboratories (Inst); Alpine Immune Sciences (Inst); Amgen (Inst); Apollomics (Inst); AstraZeneca (Inst); AtriCure (Inst); Axelia Oncology (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CStone Pharmaceuticals (Inst); Cullinan Oncology (Inst); Dizal Pharma (Inst); Eucure Biopharma (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genfleet Therapeutics (Inst); GlaxoSmithKline (Inst); IMPAC Medical Systems (Inst); InventisBio (Inst); InxMed (Inst); Kinnate Biopharma (Inst); Lilly (Inst); Maxinovel (Inst); Relay Therapeutics (Inst); Turning Point Therapeutics (Inst); Tyra Biosciences (Inst); Vivace Therapeutics (Inst)